TestGene, the resident of ULNANOTECH, enters the Global market
22 Jul 2015
The first kits for fetal gender and Rhesus factor detection in pregnant woman blood were delivered within cooperation with the Iranian Institute of Cell and Gene Therapy (iiCGT).
TestGene is an experienced team of developers, which are constantly improving their products using latest scientific achievements. As explained by Vitaly Oginsky, Business Development Director of TestGene “we are making serious efforts to enter overseas markets, Iran's capacity is estimated to 300,000 pregnant women per year. The joint goal of TestGene and iiCGT is to satisfy 30% of total market demand during next two years. TestGene will support the new partner in technical and marketing issues, and participate in quality control of test results.